The forthcoming results season will show how COVID-19 has hit corporate Australia and capital raisings will inevitably follow.
Right now we are in the eye of the capital raising storm.
Listed entities needing COVID-19 equity came to market with great success in the first half of the year. Despite some criticisms, the vast majority of large holders followed their money into these raisings. Smaller holders took advantage of the discounts on offer and there appeared to be an almost endless stream of cash from other sources supporting these “asks”.
The forthcoming results season will show how COVID-19 has hit corporate Australia. Capital raisings will inevitably follow.
So it is a good time to pause and think about a key learning of that first wave.
It is crystal clear that Australia has the best regulatory settings for equity capital raisings in the world. The statistics bear that out – Australia accounted for US$22 billion ($31.7 billion) of the capital raised globally in the first half of the year and led the rebound in global equity issuances from the beginning of the pandemic until early May.
An astounding and disproportionate result on any measure, especially as Australia represents only 2 per cent of the Morgan Stanley Capital Index. Of course, size alone is not the true measure of success. Market integrity and positive sentiment are also important factors.
It is too early to tell for the raisings so far, but the experience during and since the 2008 financial crisis provides validation. Very few raisings have been suspect and typically those who participated prospered. Meanwhile, Australian listed entities have weathered these storms well.
However, some small institutional holders and high net worth individuals have felt left out in the cold. They are too small to get the “institutional tranche” call when placement bookbuilds are arranged at speed, but too large to get their pro rata share from the share purchase plan (SPP) that follows (SPPs cap out at a $30,000 investment).
Issuers and underwriters have done their best to include those small holders through retail broker syndicates, but this can sometimes be hit and miss. And while a rights issue would give those left in the cold that pro rata opportunity, rights issues pose timing issues for underwriters seeking to get “off risk” quickly, liability disadvantages for issuers and can be less advantageous to small holders than an SPP.